• bioAffinity Technologies will attend the Lung Cancer Initiative of North Carolina's Battle of the Blues on Nov. 5, 2026.
• The event will highlight lung cancer diagnostics and therapies, including the company's noninvasive CyPath Lung test for early detection.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. bioAffinity Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610290800BIZWIRE_USPR_____20261029_BW718789) on October 29, 2026, and is solely responsible for the information contained therein.